Targeted delivery of biomolecules such as proteins, mRNAs, and DNA editing complexes is one of the biggest challenges in realizing the promise of treating many diseases. Emerging research is demonstrating the potential of engineering viral capsids directly as vehicles and/or as inspirations for designing new nanocarrier delivery systems. This approach is attractive because viral capsid proteins have evolved to assemble, package cargoes, exit cells to form extracellular virions, and enter new cells. I will review several natural carrier systems in which increasing structural and biochemical knowledge has provided the opportunity to re-design and improve upon their native properties. I will also review systems in which our increasing understanding of the sophisticated functions of capsid proteins has inspired the de-novo design of self-assembling protein nanocages. These approaches couple symmetric modelling with computational design of new protein–protein interfaces to generate new protein assemblies with atomic level accuracy. The computationally designed nanocages can then be further optimized using directed evolution approaches to optimize their biophysical properties and to incorporate desirable functions that are tailored to specific applications. Following these general principles, we have engineered protein nanocages that direct their own release from human cells inside small membrane enclosed vesicles in a manner that resembles viral assembly and release pathways. Robust enveloped protein nanocage (EPN) biogenesis requires three elements: membrane binding, self-assembly, and recruitment of the cellular ESCRT pathway (endosomal sorting complexes required for transport). When these elements are present, EPNs can be released from cells within small membrane enclosed vesicles that each contain multiple nanocages. We have identified various combinations of membrane binding, self-assembly, and ESCRT recruiting elements that can produce EPNs efficiently, indicating that the strategy is very general. EPNs pseudotyped with viral fusion proteins can enter target cells, thereby transferring their cargos from one cell to another. I will discuss how we are now extending these systems to create new synthetic delivery systems based on the principles of virus assembly and entry.